CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status.

@article{Hobson2000CRESTR,
  title={CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status.},
  author={Robert W. Hobson},
  journal={Seminars in vascular surgery},
  year={2000},
  volume={13 2},
  pages={139-43}
}
The Carotid Revascularization Endarterectomy versus Stent Trial (CREST) contrasts the relative efficacy of carotid endarterectomy (CEA) and carotid angioplasty-stent (CAS) in preventing primary outcomes of stroke, myocardial infarction, or death during a 30-day periprocedural period, or ipsilateral stroke over the follow-up period extending up to 4 years. Stroke events will be verified by an Adjudication Committee masked to the assigned treatment. The primary eligibility criterion is a… CONTINUE READING